ProfileGDS4718 / 225757_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 87% 64% 88% 85% 72% 69% 85% 86% 86% 82% 87% 72% 67% 72% 79% 81% 79% 76% 86% 84% 83% 84% 86% 86% 73% 86% 61% 86% 74% 77% 67% 88% 84% 67% 67% 78% 83% 86% 55% 83% 70% 73% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.631586
GSM549102patient 115, normal, homogenized [OPG study]8.612787
GSM549104patient 119, normal, homogenized [OPG study]6.4479164
GSM549108patient 138, normal, homogenized [OPG study]8.7727788
GSM549119patient 077, normal, homogenized [OPG study]8.4622785
GSM549133patient 032, cancer, homogenized [OPG study]7.1578672
GSM549139patient 042, cancer, homogenized [OPG study]6.8183669
GSM549099patient 107, normal, homogenized [OPG study]8.3434285
GSM549109patient 139, normal, homogenized [OPG study]8.5873886
GSM549110patient 046, normal, homogenized [OPG study]8.5993286
GSM549114patient 063, normal, homogenized [OPG study]8.2212382
GSM549122patient 082, normal, homogenized [OPG study]8.7419987
GSM549134patient 033, cancer, homogenized [OPG study]7.0512872
GSM549136patient 036, cancer, homogenized [OPG study]6.6105567
GSM549140patient 044, cancer, homogenized [OPG study]7.1268772
GSM549111patient 047, normal, homogenized [OPG study]7.8166379
GSM549113patient 057, normal, homogenized [OPG study]8.1117681
GSM549132patient 031, cancer, homogenized [OPG study]7.8093679
GSM549137patient 038, cancer, homogenized [OPG study]7.4626176
GSM549142patient 047, cancer, homogenized [OPG study]8.2243586
GSM549100patient 110, normal, homogenized [OPG study]8.2842584
GSM549107patient 135, normal, homogenized [OPG study]8.2740183
GSM549115patient 068, normal, homogenized [OPG study]8.4811284
GSM549116patient 072, normal, homogenized [OPG study]8.6395786
GSM549120patient 078, normal, homogenized [OPG study]8.5571386
GSM549131patient 030, cancer, homogenized [OPG study]7.2266473
GSM549118patient 074, normal, homogenized [OPG study]8.640886
GSM549129patient 027, cancer, homogenized [OPG study]6.2279661
GSM549123patient 088, normal, homogenized [OPG study]8.675586
GSM549124patient 006, cancer, homogenized [OPG study]7.2075674
GSM549126patient 015, cancer, homogenized [OPG study]7.5658977
GSM549128patient 025, cancer, homogenized [OPG study]6.7137967
GSM549103patient 117, normal, homogenized [OPG study]8.7110388
GSM549117patient 073, normal, homogenized [OPG study]8.476984
GSM549138patient 041, cancer, homogenized [OPG study]6.6219367
GSM549141patient 045, cancer, homogenized [OPG study]6.6857367
GSM549130patient 028, cancer, homogenized [OPG study]7.5662478
GSM549101patient 111, normal, homogenized [OPG study]8.1067383
GSM549105patient 128, normal, homogenized [OPG study]8.5648886
GSM549106patient 134, normal, homogenized [OPG study]5.7886555
GSM549112patient 048, normal, homogenized [OPG study]8.2772883
GSM549125patient 011, cancer, homogenized [OPG study]6.8888670
GSM549127patient 024, cancer, homogenized [OPG study]7.1995873
GSM549135patient 035, cancer, homogenized [OPG study]7.1714572